0000000001035202

AUTHOR

A. R. Osella

showing 3 related works from this author

Integrated Small Dense Low-density Lipoprotein Profile in Cardiovascular Disease and Cancer: A longitudinal study

2019

Background/Aim: Low-density lipoproteins (LDL) are a heterogeneous class of particles that differ in size and density from each other. Small dense LDL (sdLDL) particles are considered more atherogenic than larger particles. The aim of the study was to evaluate serum levels of sdLDL in patients who died from cardiovascular diseases (CVD) or cancer in a cohort of patients followed up in the De Bellis Research Hospital for 20 years. Patients and Methods: A total of 75 participants who died of cancer and 87 who died of CVD were enrolled and they were matched for age and sex with 135 healthy controls, i.e. without CVD or cancer and are still alive. Results: Patients who died from cancer had the …

AdultMaleCancer Researchmedicine.medical_specialtyLongitudinal studySmall dense ldlDiseaseAge and sexGastroenterologychemistry.chemical_compoundRisk FactorsInternal medicineNeoplasmsMedicineHumansIn patientLongitudinal StudiesAgedbusiness.industryCancersdLDL cardiovascular disease cancerGeneral MedicineMiddle Agedmedicine.diseasePrognosisLipoproteins LDLOncologychemistryCardiovascular DiseasesLow-density lipoproteinCase-Control StudiesCohortFemalebusinessBiomarkersFollow-Up Studies
researchProduct

Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area

2018

Coffee drinking seems to have several beneficial effects on health outcomes. However, the effect on hepatic steatosis, depending on a high alcohol consumption (AFLD, alcoholic fatty liver disease) or on metabolic factors (non-alcoholic fatty liver disease, NAFLD), is still equivocal. Thus, we aimed to explore the potential association between coffee consumption and the presence and severity of hepatic steatosis in people with NAFLD or AFLD. In this cross-sectional study, coffee drinking was recorded using a semi-quantitative food frequency questionnaire, and categorized as yes vs. no and as 0, 1, 2, ≥3. The degree of fatty liver was assessed through a standardized ultrasound examination (sc…

MaleCross-sectional studyBlood PressureGastroenterologyBody Mass Indexchemistry.chemical_compound0302 clinical medicineNon-alcoholic Fatty Liver DiseaseSurveys and QuestionnairesPrevalencecaffeineAged 80 and overNutrition and DieteticsultrasoundMediterranean RegionFatty liverMiddle Aged3. Good healthItaly030220 oncology & carcinogenesisPopulation study030211 gastroenterology & hepatologyepidemiologyFemaleWaist CircumferenceCaffeinelcsh:Nutrition. Foods and food supplyFatty Liver AlcoholicAdultmedicine.medical_specialtyAlcohol Drinkingcoffeelcsh:TX341-641Article03 medical and health sciencesInternal medicinemedicineHumansfatty liver; coffee; caffeine; ultrasound; epidemiologyfatty liverAgedbusiness.industrycaffeine; coffee; epidemiology; fatty liver; ultrasoundOdds ratiomedicine.diseaseCross-Sectional StudiesLogistic ModelschemistryAlcoholic fatty liverSteatosisbusinessBody mass indexFood ScienceNutrients; Volume 10; Issue 1; Pages: 89
researchProduct

Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans.

2018

Background & Aims: The use of ultrasound scan (US) in non-alcoholic fatty liver disease (NAFLD) screening overloads US waiting lists. We hypothesized and tested a hybrid two-step method, consisting of applying a formula, to exclude subjects at low risk, before US. Methods: The sample included 2970 males and females (937 with NAFLD) diagnosed by US. We selected eight formulas: Fatty Liver Index (FLI), Hepatic Steatosis Index (HIS), body mass index (BMI), waist circumference (WC), Abdominal Volume Index (AVI), waist-to-height ratio (WHtR), waist/height0.5 (WHT.5R) and Body Roundness Index (BRI), and calculated their performance in the two-step method evaluating percentage reduction of the…

AdultMalemedicine.medical_specialtyDiagnostic methodsWaistGastroenterologyBody Mass Index03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineScreening methodMedicineHumansAgedUltrasonographyHepatologyAnthropometrybusiness.industryWaist-Hip RatioFatty liverUltrasoundnutritional and metabolic diseasesPercentage reductionMiddle Agedmedicine.diseasescreening NAFLDItalyROC Curve030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleSteatosisWaist CircumferencebusinessBody mass indexLiver international : official journal of the International Association for the Study of the Liver
researchProduct